chr7-45891962-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000596.4(IGFBP1):c.550G>A(p.Val184Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,613,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000596.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGFBP1 | NM_000596.4 | c.550G>A | p.Val184Ile | missense_variant | 3/4 | ENST00000275525.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGFBP1 | ENST00000275525.8 | c.550G>A | p.Val184Ile | missense_variant | 3/4 | 1 | NM_000596.4 | P4 | |
IGFBP1 | ENST00000457280.5 | c.550G>A | p.Val184Ile | missense_variant | 3/4 | 5 | A2 | ||
IGFBP1 | ENST00000468955.1 | c.520-998G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251368Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135864
GnomAD4 exome AF: 0.0000814 AC: 119AN: 1461576Hom.: 0 Cov.: 30 AF XY: 0.0000798 AC XY: 58AN XY: 727096
GnomAD4 genome AF: 0.000348 AC: 53AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 28, 2023 | The c.550G>A (p.V184I) alteration is located in exon 3 (coding exon 3) of the IGFBP1 gene. This alteration results from a G to A substitution at nucleotide position 550, causing the valine (V) at amino acid position 184 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at